Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial dilated cardiomyopathy.

Elisabete Martins1, José Silva Cardoso, Cassiano Abreu-Lima

  • 1Serviço de Cardiologia do Hospital de São João, Porto. bernardes_med@hotmail.com

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|March 8, 2003
PubMed
Summary

Dilated cardiomyopathy, a leading cause of heart failure, is increasingly recognized as having genetic links. Research into familial dilated cardiomyopathy offers new insights into its causes and potential treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical guide on acute heart failure management: From hospital admission to outpatient care.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026
Same author

Staging of Fabry cardiomyopathy in clinical practice: an algorithm proposal.

International journal of cardiology. Heart & vasculature·2026
Same author

[Use of Natriuretic Peptides in the Diagnosis of Heart Failure in Primary Healthcare in Portugal: A Proposal from Clinical and Laboratory Experts].

Acta medica portuguesa·2026
Same author

Metabolic Outcomes in Bariatric/Metabolic Surgery Individuals: Impact of Metabolic Health Definition, Type of Surgery, and Follow-Up Duration-An Observational, Retrospective Study.

Metabolites·2026
Same author

Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2025
Same author

Fabry Disease Screening in Patients with Idiopathic HCM or LVH: Data from the Multicentric Nationwide F-CHECK Study.

Biomedicines·2025

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is the most common cause of heart failure, characterized by ventricular dilation and reduced systolic function.
  • Historically considered idiopathic, DCM now includes secondary forms (e.g., ischemic, hypertensive) and a significant familial component (up to 30% of idiopathic cases).
  • Inheritance patterns vary, with autosomal dominant being most common, alongside X-linked, autosomal recessive, and mitochondrial forms.

Purpose of the Study:

  • To explore the genetic underpinnings of familial dilated cardiomyopathy.
  • To understand the molecular basis of cardiac dilatation and protein dysfunction in DCM.
  • To highlight the importance of genetic research in advancing DCM pathogenesis understanding and treatment.

Main Methods:

Related Experiment Videos

  • Review of existing literature on familial dilated cardiomyopathy.
  • Analysis of genetic loci and protein-coding genes associated with cardiac dilatation.
  • Consideration of molecular interactions contributing to disease presentation.

Main Results:

  • Familial occurrence accounts for a substantial portion of idiopathic DCM cases.
  • Mutations in genes encoding sarcomeric, cytoskeletal, and nuclear lamina proteins are implicated in DCM.
  • Interactions between mutated proteins and environmental factors can influence clinical presentation.

Conclusions:

  • Dilated cardiomyopathy has significant genetic contributions, necessitating a shift from viewing it as solely idiopathic.
  • Understanding the genetic basis of DCM is crucial for developing targeted therapies.
  • Recent guidelines from the European Society of Cardiology emphasize the study of familial DCM.